Advances in Hematological Malignancies
Recent decades have witnessed remarkable strides in the domain of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and manipulation are transforming the survival rates for patients with blood cancers. Research studies continue to explore these innovative strategies, offering potential for more success